IL6 and coronary artery disorder: The study findings indicate that the mice treated agomir-miR-19a/b exhibited elevated levels of IFN-γ compared to the mice with CHD, as illustrated in Figure 3E. Furthermore, the significant pro-inflammatory factors IL-1β and IL-6 exhibited an increase in mice with CHD.